UVV UNIVERSAL CORP /VA/
Wholesale-Farm Product Raw Materials · NYSE · SEC CIK 102037 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-9.4%
TTM net income YoY-102.2%
TTM EPS YoY-102.3%
Revenue 3-yr CAGR0.7%
Net income 3-yr CAGR—
Margins
Gross margin15.2%
Operating margin4.2%
Net margin-0.1%
FCF margin0.9%
EBITDA margin6.1%
Returns
ROE-0.2%
ROA-0.1%
ROIC (approx.)3.5%
Asset turnover0.88x
Leverage & solvency
Liabilities / assets53.0%
Debt / equity0.86x
Current ratio2.54x
Interest coverage1.58x
Cash quality & payout
Operating cash flow / net income-35.60x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue2.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.89B | $2.92B |
| Cost of revenue | $2.41B | $2.40B |
| Gross profit | $472.62M | $524.30M |
| SG&A expense | $300.67M | $305.29M |
| Operating income | $168.45M | $232.80M |
| Interest expense | $74.04M | $79.64M |
| Pretax income | $102.65M | $154.22M |
| Income tax | $46.66M | $40.95M |
| Net income | $32.64M | $95.05M |
| EBITDA | $221.89M | $292.57M |
| EPS (basic) | 1.30 | 3.81 |
| EPS (diluted) | 1.30 | 3.78 |
| Dividends declared per share | 3.28 | 3.24 |
| Weighted avg. shares (diluted) | 25.17M | 25.13M |
| Banking | ||
| Provision for credit losses | $6.26M | $1.94M |
| Balance sheet | ||
| Cash & equivalents | $62.18M | $260.12M |
| Receivables | $563.86M | $625.88M |
| Current assets | $1.97B | $2.16B |
| PP&E, net | $372.95M | $372.97M |
| Goodwill | $172.69M | $213.84M |
| Intangibles | $48.60M | $57.84M |
| Total assets | $2.77B | $2.99B |
| Current liabilities | $564.24M | $750.16M |
| Short-term debt | $287.56M | $0 |
| Long-term debt | $616.73M | $617.92M |
| Total debt | $904.29M | $617.92M |
| Total liabilities | $1.31B | $1.49B |
| Shareholders' equity | $1.42B | $1.46B |
| Net debt | $842.11M | $357.80M |
| Shares outstanding | 24.92M | 24.72M |
| Cash flow statement | ||
| Operating cash flow | $129.10M | $326.97M |
| Capital expenditure | $48.83M | $62.60M |
| Free cash flow | $80.27M | $264.37M |
| Investing cash flow | -$42.96M | -$58.82M |
| Financing cash flow | -$284.34M | -$63.23M |
| Depreciation & amortization | $53.44M | $59.77M |
| Stock-based compensation | $7.12M | $8.53M |
| Dividends paid | $81.30M | $79.69M |
| Share buybacks | $0 | $0 |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.